← FDA DRUG APPROVALS

FDA ANDA · ANDA215548

FENOPROFEN CALCIUM

Sponsor: MISEMER

APPLICATION
ANDA215548
TYPE
ANDA
ORIGINAL APPROVAL
2023-05-16
LATEST ACTION
2023-05-16
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FENOPROFEN CALCIUMDiscontinued
FENOPROFEN CALCIUM EQ 300MG BASE · CAPSULE · ORAL
FENOPROFEN CALCIUMDiscontinued
FENOPROFEN CALCIUM EQ 400MG BASE · CAPSULE · ORAL
FENOPROFEN CALCIUMDiscontinued
FENOPROFEN CALCIUM EQ 200MG BASE · CAPSULE · ORAL

Approval history

2023-05-16UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →